+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Paediatric Consumer Health in Japan

  • PDF Icon

    Report

  • 28 Pages
  • September 2024
  • Region: Japan
  • Euromonitor International
  • ID: 4750530
Paediatric consumer health in Japan is set to see insignificant retail current value growth in 2024, remaining almost flat overall. Looking at the different categories, paediatric analgesics and paediatric cough, cold and allergy remedies are expected to see above-average performances, benefiting from the sustained high incidence of various infectious diseases in 2024, such as COVID-19, colds, and flu, similar to adult products.

The Paediatric Consumer Health in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Paediatric Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2024 DEVELOPMENTS
  • Outbreaks of common colds, influenza, and COVID-19 support sales
  • Protein for children increasingly valued
  • Dietary supplements for families
PROSPECTS AND OPPORTUNITIES
  • The impact of the low birth rate in Japan
  • Solutions to “modern malnutrition”
  • The continued development of paediatric medicines due to government intervention
CATEGORY DATA
  • Table 1 Sales of Paediatric Consumer Health by Category: Value 2019-2024
  • Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
  • Table 3 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
  • Table 4 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
  • Table 5 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
  • Table 6 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN JAPAN
EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2019-2024
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources